Breast Cancer Research

official impact factor 5.79

Review

High-throughput genomic technology in research and clinical management of breast cancer. Molecular signatures of progression from benign epithelium to metastatic breast cancer

Karin Rennstam and Ingrid Hedenfalk*

Breast Cancer Research 2006, 8:213 doi:10.1186/bcr1528

No comments have yet been made on this article.

Post a comment